Gene Patenting

August 2011

This webinar addresses gene patenting and its implications for women around the world. Participants learn about the latest news in the Myriad Genetics case, along with the basic science, patent law, and current campaign efforts. Breast Cancer Action is a plaintiff in the lawsuit to invalidate Myriad Genetics’ patents on the breast cancer genes BRCA 1 and 2 because patients should always come before profits.

Past Webinars